Fig. S3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

Aoki, Kazunori; Nishito, Yukari; Motoi, Noriko; Arai, Yasuhito; Hiraoka, Nobuyoshi; Shibata, Tatsuhiro; Sonobe, Yukiko; Kayukawa, Yoko; Hashimoto, Eri; Takahashi, Mina; Fujii, Etsuko; Nishizawa, Takashi; Fukuda, Hironori; Ohashi, Kana; Arai, Kosuke; Mizoguchi, Yukihiro; Yoshida, Yukihiro; Watanabe, Shun-ichi; Yamashita, Makiko; Kitano, Shigehisa; Sakamoto, Hiromi; Nagata, Yuki; Mitsumori, Risa; Ozaki, Kouichi; Niida, Shumpei; Kanai, Yae; Hirayama, Akiyoshi; Soga, Tomoyoshi; Maruyama, Toru; Tsukada, Keisuke; Yabuki, Nami; Shimada, Mei; Kitazawa, Takehisa; Natori, Osamu; Sawada, Noriaki; Kato, Atsuhiko; Yoshida, Teruhiko; Yasuda, Kazuki; Mizuno, Hideaki; Tsunoda, Hiroyuki; Ochiai, Atsushi

doi:10.1158/2767-9764.23508991.v1

Fig. S3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

https://doi.org/10.1158/2767-9764.23508991

journal contribution

posted on 2023-06-13, 14:20 authored by Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Takashi Nishizawa, Hironori Fukuda, Kana Ohashi, Kosuke Arai, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun-ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi Ozaki, Shumpei Niida, Yae Kanai, Akiyoshi Hirayama, Tomoyoshi Soga, Toru Maruyama, Keisuke Tsukada, Nami Yabuki, Mei Shimada, Takehisa Kitazawa, Osamu Natori, Noriaki Sawada, Atsuhiko Kato, Teruhiko Yoshida, Kazuki Yasuda, Hideaki Mizuno, Hiroyuki Tsunoda, Atsushi Ochiai

<p>Number of each immune cell type, CD4+ T cell subset, and CD8 T+ cell subset by FCM from lung cancer and NATs. (a) Cell density of each immune cell type. Data are presented as the number of indicated immune cells per gram of NAT, LUAD, LUSQ, and other types of lung cancer tissues. (b, c) Density of CD4+ T cell subset (b) and CD8+ T cell subset (c). ns; not significant. * p<0.05. **P<0.01. ***P<0.001. ****P<0.0001.</p>

Funding

Japan Agency for Medical Research and Development (AMED)

National Cancer Center Japan (NCC)

MEXT | Japan Society for the Promotion of Science (JSPS)

History

Related Materials

1.
DOI - Is supplement to Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

ARTICLE ABSTRACT

The precise TIL profiling classified NSCLC into novel three immune subtypes that correlates with patient outcome, identifying subtype-specific molecular pathways and genomic alterations that should play important roles in constructing subtype-specific immune tumor microenvironments. These classifications of NSCLC based on TIL status are useful for developing personalized immune therapies for NSCLC.